Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3745-3753
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3745
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3745
Immune function indicators | Stage | Group S (n = 35) | Group L (n = 35) | t | P value |
CD4+ (%) | Before analgesic treatment | 29.67 ± 5.91 | 29.45 ± 5.72 | 0.158 | 0.875 |
After analgesic treatment | 26.05 ± 4.76a | 29.18 ± 5.64 | 2.509 | 0.014 | |
CD8+ (%) | Before analgesic treatment | 25.16 ± 4.25 | 25.37 ± 4.48 | 0.201 | 0.841 |
After analgesic treatment | 29.23 ± 3.89a | 26.28 ± 3.75 | 3.230 | 0.002 | |
CD4+/CD8+ | Before analgesic treatment | 1.06 ± 0.23 | 1.04 ± 0.21 | 0.378 | 0.705 |
After analgesic treatment | 0.83 ± 0.17a | 0.97 ± 0.12 | 3.980 | < 0.001 |
- Citation: Qian J, Wu J, Zhu J, Qiu J, Wu CF, Hu CR. Effect of hyperthermia combined with opioids on cancer pain control and surgical stress in patients with gastrointestinal cancer. World J Gastrointest Surg 2024; 16(12): 3745-3753
- URL: https://www.wjgnet.com/1948-9366/full/v16/i12/3745.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i12.3745